Introduction
Nitazoxanide is a broad-spectrum antiparasitic that has been tested for
COVID-19 due to the anti-inflammatory effects and in vitroanti-viral activity and promising clinical benefits against influenza
and other viruses. The aim of this study was to synthesize the best
evidence on the efficacy and safety of nitazoxanide as treatment for
patients with COVID-19.